OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Neural Transmission is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Ried	55
Recent update on the heterogeneity of the Alzheimer’s disease spectrum	55
Dystonia updates: definition, nomenclature, clinical classification, and etiology	46
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration	42
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity	42
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials	40
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease	40
Impact of the COVID-19 lockdown on screen media use in patients referred for ADHD to child and adolescent psychiatry: an introduction to problematic use of the internet in ADHD and results of a survey	39
Language in autism: domains, profiles and co-occurring conditions	38
Contemporary functional neuroanatomy and pathophysiology of dystonia	36
Viruses, parkinsonism and Parkinson’s disease: the past, present and future	35
ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning	33
Neuronal intranuclear inclusion disease: recognition and update	31
Glucocerebrosidase mutations and Parkinson disease	30
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease	30
Emerging and converging molecular mechanisms in dystonia	30
The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models	30
A brief history of brain iron accumulation in Parkinson disease and related disorders	28
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview	26
The heterogeneity of Parkinson’s disease	26
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice	26
COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study)	25
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease	25
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t	24
GBA-associated PD: chances and obstacles for targeted treatment strategies	24

Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors	23
Improvement of brain functional connectivity in autism spectrum disorder: an exploratory study on the potential use of virtual reality	23
Neuropsychological functioning of individuals at clinical evaluation of adult ADHD	22
Cognitive characterization of adult attention deficit hyperactivity disorder by domains: a systematic review	22
Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson’s disease: mutational spectrum and clinical features	22
SIRT1 and SIRT2 modulators reduce LPS-induced inflammation in HAPI microglial cells and protect SH-SY5Y neuronal cells in vitro	22
Parkinson and depression: review and outlook	22
Genes and hormones of the hypothalamic–pituitary–adrenal axis in post-traumatic stress disorder. What is their role in symptom expression and treatment response?	20
Metacognition in adult ADHD: subjective and objective perspectives on self-awareness of cognitive functioning	20
Morphological basis of Parkinson disease-associated cognitive impairment: an update	20
Long-term effects of chronic stress models in adult mice	20
Neurodegenerative proteinopathies associated with neuroinfections	19
Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis	19
Feigning ADHD and stimulant misuse among Dutch university students	19
Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan	19
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network	18
Protein clearance strategies for disease intervention	18
Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids	17
Isolated dystonia: clinical and genetic updates	17
The pathobiological basis of depression in Parkinson disease: challenges and outlooks	17
ADHD and offending	17
Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis	16
Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders	16
Emergent creativity in frontotemporal dementia	16
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress	16
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease	16
The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease	15
Blood neurofilament light chain in Parkinson’s disease	15
Hemispheric asymmetries in mental disorders: evidence from rodent studies	15
Synaptic plasticity mechanisms behind TMS efficacy: insights from its application to animal models	15
Evaluation for Parkinsonian Bradykinesia by deep learning modeling of kinematic parameters	15
Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy	15
Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations	15
Autism Spectrum Disorder and auditory sensory alterations: a systematic review on the integrity of cognitive and neuronal functions related to auditory processing	15
Beyond tics: movement disorders in patients with Tourette syndrome	15
Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease	14
Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases	14
Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort	14
Tau proteins in blood as biomarkers of Alzheimer’s disease and other proteinopathies	14
Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients	14
Stress and pain: modality-specific opioid mediation of stress-induced analgesia	14
Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia	14
The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder	13
Effects of head trauma and sport participation in young-onset Parkinson’s disease	13
Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease	13
Life style and Parkinson’s disease	13
Botulinum toxin therapy: past, present and future developments	13
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS)	13
Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset	13
Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach	13

Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors	13
Is the vertex a good control stimulation site? Theta burst stimulation in healthy controls	12
Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update	12
Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017	12
Essential tremor plus rest tremor: current concepts and controversies	12
Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study	12
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	12
Genetic updates on paroxysmal dyskinesias	12
Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson’s disease	12
Complex dystonias: an update on diagnosis and care	12
Current experimental disease-modifying therapeutics for multiple system atrophy	11
Depression in dementia with Lewy bodies: a critical update	11
The use of wearables for the diagnosis and treatment of Parkinson’s disease	11
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment	11
The enigma of vascular depression in old age: a critical update	11
Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients	11
Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits	11
Interleukin-6 secretion upon acute psychosocial stress as a potential predictor of psychotherapy outcome in posttraumatic stress disorder	11
Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer’s disease	11
Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly	10
Association of early and later depressive symptoms with functional outcome after ischemic stroke	10
Disease modification in Parkinsonism: obstacles and ways forward	10
Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson’s disease in the MARK-PD study	10
Implications of dopaminergic medication withdrawal in Parkinson’s disease	10
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models	10
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles	10
C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy	10
Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors	9
Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson’s disease	9
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone	9
Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease	9
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19	9
Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients	9
Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated multiple sclerosis syndrome	9
The importance of genetic testing for dystonia patients and translational research	9
Gaze behavior is associated with the cortisol response to acute psychosocial stress in the virtual TSST	9
Abnormal cerebellum connectivity patterns related to motor subtypes of Parkinson’s disease	9
Non-credible symptom report in the clinical evaluation of adult ADHD: development and initial validation of a new validity index embedded in the Conners’ adult ADHD rating scales	9
Associations of age, sex, sexual abuse, and genotype with monoamine oxidase a gene methylation	9
Voxel-based lesion symptom mapping analysis for dysphagia in stroke patients with isolated cerebellar lesions	9
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes	9
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study	8
The role of stress coping strategies for life impairments in ADHD	8
GenIDA: an international participatory database to gain knowledge on health issues related to genetic forms of neurodevelopmental disorders	8
Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?	8
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016	8
X-linked dystonia Parkinsonism: crossing a new threshold	8
Oscillatory activity in the BNST/ALIC and the frontal cortex in OCD: acute effects of DBS	8
Issues for patchy tissues: defining roles for gut-associated lymphoid tissue in neurodevelopment and disease	8
Small intestinal bacterial overgrowth in Alzheimer’s disease	8
Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis	8
New modalities and directions for dystonia care	8
Associations between age and cortisol awakening response in patients with borderline personality disorder	8
Public perceptions of adult ADHD: Indications of stigma?	8
Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study	8
The impact of maternal care and blood glucose availability on the cortisol stress response in fasted women	8
Genetic testing for Parkinson’s disease in clinical practice	8
Impact of the COVID-19 pandemic on mental health and family situation of clinically referred children and adolescents in Switzerland: results of a survey among mental health care professionals after 1	8
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review	8
Assessment and treatment of substance use in adults with ADHD: a psychological approach	8
Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis	7
Efficacy of adjunctive d-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials	7
Resting-state network connectivity changes in drug-naive Parkinson’s disease patients with probable REM sleep behavior disorder	7
Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations	7
Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder	7
More focal, less heterogeneous? Multi-level meta-analysis of cathodal high-definition transcranial direct current stimulation effects on language and cognition	7
Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels	7
Sex differences in schizophrenia: a longitudinal methylome analysis	7
Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?	7
The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin	7
Polymorphisms of COMT and CREB1 are associated with treatment-resistant depression in a Chinese Han population	7
Insights into Lewy body disease from rare neurometabolic disorders	7
Dystonia and leveraging oral pharmacotherapy	7
Dual task gait deteriorates gait performance in cervical dystonia patients: a pilot study	7
A sudden and severe depressive episode after a left cingulate gyrus stroke: a case report of post-stroke depression and review of literature	7
Changes in the TMS-evoked potential N100 in the dorsolateral prefrontal cortex as a function of depression severity in adolescents	7
Treadmill training and physiotherapy similarly improve dual task gait performance: a randomized-controlled trial in Parkinson’s disease	7
Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease	7